
|Articles|August 25, 2017
New Specialty Drug Indications of 2017
Author(s)Lauren Santye, Assistant Editor
Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year.
Advertisement
The process of bringing a drug to market is expensive and can take several years. In response, the industry has taken to recycling failed and existing medications for novel indications.
As specialty drugs continue to leave a mark on the health care space, take a look at specialty medications previously approved by the FDA that received new indications in 2017, thus far.
Graphic by Gwen Salas
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About High-Dose Semaglutide’s Safety Profile
2
Ensitrelvir Demonstrates Significant COVID-19 Post-Exposure Prophylaxis Efficacy in Phase 3 Trial
3
Pharmacist Interventions Impact Bottom Line in a Neurology Clinic
4
Declining Vitamin K Prophylaxis in Newborns: A Growing Threat to Neonatal Safety
5
































































































































